CoChat

Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy

Open access
Ma, Chao, Cheung, Ann F., Chodon, Thinle, Koya, Richard C., Wu, Zhongqi, Ng, Charles, Avramis, Earl, Cochran, Alistair J., Witte, Owen N., Baltimore, David, Chmielowski, Bartosz, Economou, James S., Comin-Anduix, Begonya, Ribas, Antoni, Heath, James R. · 2013 · Cancer Discovery
Cited by 144

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Adoptive cell transfer (ACT) of genetically engineered T cells expressing cancer-specific T-cell receptors (TCR) is a promising cancer treatment. Here, we investigate the in vivo functional activity and dynamics of the transferred cells by analyzing samples from 3 representative patients with melanoma enrolled in a clinical trial of ACT with TCR transgenic T cells targeted against the melanosomal antigen MART-1. The analyses included evaluating 19 secreted proteins from individual cells from phenotypically defined T-cell subpopulations, as well as the enumeration of T cells with TCR antigen specificity for 36 melanoma antigens. These analyses revealed the coordinated functional dynamics of the adoptively transferred, as well as endogenous, T cells, and the importance of highly functional T cells in dominating the antitumor immune response. This study highlights the need to develop approaches to maintaining antitumor T-cell functionality with the aim of increasing the long-term efficacy of TCR-engineered ACT immunotherapy. Significance: A longitudinal functional study of adoptively transferred TCR–engineered lymphocytes yielded revealing snapshots for understanding the changes of antitumor responses over time in ACT immunotherapy of patients with advanced melanoma. Cancer Discov; 3(4); 418–29. ©2013 AACR. See related commentary by Speiser, p. 379 This article is highlighted in the In This Issue feature, p. 363

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-12-0383

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 144

Metadata

Authors
Ma, C., Cheung, A. F., Chodon, T., Koya, R. C., Wu, Z., Ng, C., Avramis, E., Cochran, A. J., Witte, O. N., Baltimore, D., Chmielowski, B., Economou, J. S., Comin-Anduix, B., Ribas, A., & Heath, J. R.
Venue
Cancer Discovery
Published
2013-04-01
Volume
3
Issue
4
Pages
418-429
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2100634642
Cited by
144
References
9
FWCI
4.58
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy. https://app.cochat.ai/papers/10.1158/2159-8290.cd-12-0383
The paper
Ma, C., Cheung, A. F., Chodon, T., Koya, R. C., Wu, Z., Ng, C., Avramis, E., Cochran, A. J., Witte, O. N., Baltimore, D., Chmielowski, B., Economou, J. S., Comin-Anduix, B., Ribas, A., & Heath, J. R. (2013). Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-12-0383

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.